Glucuronidation of Buprenorphine and Norbuprenorphine by Human Liver Microsomes and UDP-Glucuronosyltransferases

E-ISSN： 1874-0758|3|2|101-107

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.3, Iss.2, 2009-04, pp. : 101-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver

By Mano Yuji Usui Takashi Kamimura Hidetaka

European Journal of Clinical Pharmacology, Vol. 63, Iss. 3, 2007-03 ,pp. : 289-296

Springer Publishing Company

Access to resources Recommend Favorite

Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators

By Knights Kathleen M. Miners John O.

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 63-73

Informa Healthcare

Access to resources Recommend Favorite

UDP-Glucuronosyltransferases

Current Drug Metabolism, Vol. 1, Iss. 2, 2000-01 ,pp. : 143-161

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Human UDP-Glucuronosyltransferase Responsible for the Glucuronidation of Niflumic Acid in Human Liver

By Mano Yuji Usui Takashi Kamimura Hidetaka

Pharmaceutical Research, Vol. 23, Iss. 7, 2006-07 ,pp. : 1502-1508

Springer Publishing Company

Access to resources Recommend Favorite

Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7

By Tsoutsikos P. Miners J.O. Stapleton A. Thomas A. Sallustio B.C. Knights K.M.

Biochemical Pharmacology, Vol. 67, Iss. 1, 2004-01 ,pp. : 191-199

Elsevier

Access to resources Recommend Favorite